Latest stories on PCVX
PolarityBio Highlights Highest Scoring Abstract Award and Presentation of Phase 3 COVER DFUS II Trial Results at SAWC Fall 2026
GlobeNewswire63 · neutralproduct/pr
Cantor Fitzgerald reiterates Vaxcyte stock rating on OPUS-1 data
Investing.com Analyst Ratings52 · neutralanalyst
Vaxcyte: Vaccine Titan In The Making
Seeking Alpha63 · neutralgeneral
Cantor Fitzgerald sets Vaxcyte stock price target at $120
Investing.com Analyst Ratings63 · neutralanalyst
Vaxcyte, Inc. (PCVX) files 8-K
SEC 8-K53 · neutralgeneral
Vaxcyte Prices $1 Billion Financing Mix as VAX-31 Clinical and Launch Spending Ramps
October 7, 2026
MarketChameleon24 · bearishgeneral
Vaxcyte 7.412M share Spot Secondary priced at $64.00
The Fly28 · bearishgeneral
Vaxcyte prices $500M equity offering and $500M convertible notes
Seeking Alpha24 · bearishgeneral
Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
GlobeNewswire24 · bearishgeneral
Vaxcyte: 'Strong Buy' On VAX-31 Trial Win IPD VAX-31 And Additional Readouts 1st Half 2027
Seeking Alpha73 · bullishproduct/pr
Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest Losers
Investors.com28 · bearishgeneral
Vaxcyte falls -11.3%
The Fly39 · neutralgeneral
Vaxcyte VAX-31 pneumococcal vaccine phase 3 trial results - qz.com
Quartz63 · neutralproduct/pr
Vaxcyte price target raised to $146 from $130 at BofA
The Fly61 · neutralanalyst
BofA raises Vaxcyte stock price target to $146 on OPUS-1 data
Investing.com Analyst Ratings67 · bullishanalyst
Why is Vaxcyte stock sliding today?
Investing.com Markets42 · neutralgeneral
NVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage Test
Stocktwits News67 · bullishproduct/pr
Why is Vaxcyte stock sliding in after-hours trading today?
Investing.com Markets34 · bearishgeneral
Vaxcyte stock falls on $1B dual offering launch
Investing.com Markets28 · bearishgeneral
Vaxcyte files to sell $500M of common stock, $500M of convertible senior notes
The Fly24 · bearishgeneral
Vaxcyte files separate $500M offerings for equity/pre-funded warrants and 2032 convertible notes
Seeking Alpha24 · bearishgeneral
Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
GlobeNewswire28 · bearishgeneral